ClinicalTrials.gg
RecruitingNCT07938736Updated Nov 16, 2026

Quality of Life, Decision-making, Resilience, Satisfaction and Success Rate of Different IVF Treatment Strategies: an International Prospective Cohort Study

An observational study in Infertility (IVF Patients) and Success Rate, sponsored by Universitätsklinik fur Frauenheilkunde, Inselspital Bern. Recruiting at 1 site in Switzerland. Open to female participants aged 18 Years to 44 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Universitätsklinik fur Frauenheilkunde, Inselspital Bern · Observational

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 44 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 25 studies in Infertility with a site in Switzerland — 7 open to participants now, 8 under way, 1 of them phase 3. Infertility · Switzerland.

Planned enrollment
5th of 10
300 · median 250
Started
2026
the only one that year
Observational
10 of 25
5 open now
Registered
25th of 25
by date

Among the 25 studies in Infertility with a site in Switzerland, this one is the 5th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2026, is one of 10 observational ones, and was the 25th registered.

Infertility

2,089 studies on the registry are indexed under Infertility; 356 are open to participants now.

Browse Infertility studies →

Open to participants now

7 of the 25 studies in Infertility with a site in Switzerland are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 234 Infertility studies recruiting now, 43 (18%) set no upper age limit and 185 (79%) stop at 75 or younger; 27 take children under 18; 76 take healthy volunteers.

This study: 18 Years to 44 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Infertility with a site in Switzerland, or all of them as a file.
02

Study summary

Study aims to assess the quality of life and mental health of patients suffering from infertility. Secondly, this study aims to discover the true reasons for choosing a certain IVF treatment (whether quality of life related or otherwise) and the extent to which defined factors (e.g. cost, doctor recommendations, stress levels and effectiveness) influence this choice. Thirdly, the study aims to examine psychological resilience in adhering to a treatment choice and the reasons for changing treatment. Finally, we will evaluate the cumulative live birth rate over a planned timeframe, including that experienced with IVF Naturelle, as these are currently unknown.

03

Conditions studied

  • Infertility (IVF Patients)
  • Success Rate

Browse trials for

Keywords

  • IVF
  • Natural Cycle IVF
  • ART
  • QoL
  • Decision-making
04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The project population consists IVF patients who are willing to participate in this study. Patients should not have had an IVF treatment before or, if a clinical pregnancy had been achieved by IVF, a new IVF therapy should not have started since then.

After receiving advice on the advantages and disadvantages of each type of in vitro fertilisation treatment (NC/ Min-stim IVF and cIVF strategy), couples will be free to decide which IVF treatment strategy they wish to follow. Couple are also free to change treatment strategy during the 6 month treatment phase.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patient age ≥ 18 till 44
  • Indication for IVF/ICSI
  • First IVF treatment or first IVF treatment after a clinical pregnancy (spontaneous conception or pregnancy achieved by IVF)
  • Cycles with intended fresh and/or frozen ETs within 6 months (= study period)
  • In case of NC-IVF: regular menstrual cycle (Eumenorrhae = 24-38 day of cycle)

Exclusion criteria

Exclusion Criteria:

  • IVF cycle with PGT for monogenetic diseases
  • cIVF cycles with PGT for aneuploidy without the intention to have an embryo transfer within 6 months
  • Social freezing cycles
  • Medical freezing cycles
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group 1

    NC-/Min Stim IVF

  • Group 2

    cIVF

  • Group 3/Mixed IVF Group

    NC-/Min Stim IVF and cIVF

06

What researchers measure

Primary outcomes

  1. Quality of life

    Quality of life related to infertility will be analyzed using the Fertility Quality of Life (FertiQoL) questionnaire. The FertiQoL questionnaire contains 36 items in total, assessing the personal and interpersonal impact, quality of life specifically related to medical interventions, and general self-rated health and quality of life. Scores on the response scales are reversed, summed and scaled to range from 0 to 100. Higher scores on the subscales and total scores indicate better quality of life.

    Time frame: 6 months

Secondary outcomes

  1. Mental Health

    Mental health related to infertility will be analyzed using the Center for Epidemiologic Studies Depression Scale (CES-D) scale. The standard CES-D is a 20-item self-report questionnaire assessing depressive symptoms experienced over the past week. Scores range between 0 to 60. Higher scores indicate greater severity and frequency of depressive symptoms.

    Time frame: 6 months

Other outcomes

  1. Factors first choice of IVF

    Which factors have affected your first choice of IVF treatment strategy?

    Time frame: 6 months

  2. Success rate

    Number of pregnancies (clinical/ongoing), any live birth (defined as at least one delivery of a live infant resulting from all NC/Min stim-IVF, cIVF or mixed treatment cycles, inclusive frozen embryo transfer (FET) cycles until pregnancy occurred or until 6 months were over). Type of IVF (in each cycle): NC-, Min stim- and cIVF Number of miscarriages Number of ectopic pregnancies, others outcome of pregnancy Number of women who discontinue IVF treatment Premature ovulation: yes/no Number of oocytes, zygotes, embryos and frozen embryos (inclusive day of freezing) Preimplantation Genetic Testing (PGT) (yes or no) Technology of fertilization (IVF or ICSI or both) Day of embryo transfer (2, 3 or 5) Number of transferred embryos Number of frozen embryos remaining at the end of the six-month observation period (inclusive day of freezing)

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Frauenklinik Bern, Universitätspital Inselspital Bern
    Bern, Canton of Bern 3000, Switzerland
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for May 2027, 11 months after the start.

Of 209 non-industry observational studies under Infertility, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 100. This study's planned 11 months is below that.

Counting every sponsor, half of 240 studies reached it within 39 months; a quarter within 16 and three quarters within 99.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2026
First posted
Nov 16, 2026
StartActual
Jun 1, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
Aug 31, 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938736
Lead sponsor
Universitätsklinik fur Frauenheilkunde, Inselspital Bern
Responsible party
Michael von Wolff (Professor, Universitätsklinik fur Frauenheilkunde, Inselspital Bern) — Principal investigator
First posted
Nov 16, 2026
Start date
Jun 1, 2026
Primary completion
May 31, 2027 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Michael von Wolff, Professor
Contact
michael.vonwolff@insel.ch
0041 31 632 13 01

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion